• Alteogen postponed its merger with Alteogen Biologics to Feb. 16, 2027, from Dec. 29, 2026, in a corrected filing.
• The shareholder meeting moves to Jan. 15, 2027, from Nov. 27, 2026.
• Creditors’ objection period now runs from Jan. 15 through Feb. 15, 2027, versus Nov. 27 through Dec. 28, 2026.
• Merger registration is now scheduled for Feb. 17, 2027, instead of Dec. 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alteogen Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261112900267), on November 12, 2026, and is solely responsible for the information contained therein.